51 related articles for article (PubMed ID: 38755598)
21. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.
Zhou W; Zhou Y; Chen X; Ning T; Chen H; Guo Q; Zhang Y; Liu P; Zhang Y; Li C; Chu Y; Sun T; Jiang C
Biomaterials; 2021 Jan; 268():120546. PubMed ID: 33253966
[TBL] [Abstract][Full Text] [Related]
22. Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.
Jeffrey JL; Lawson KV; Powers JP
J Med Chem; 2020 Nov; 63(22):13444-13465. PubMed ID: 32786396
[TBL] [Abstract][Full Text] [Related]
23. Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.
Morrissey SM; Yan J
Trends Cancer; 2020 Jul; 6(7):550-558. PubMed ID: 32610067
[TBL] [Abstract][Full Text] [Related]
24. Trauma induces expansion and activation of a memory-like Treg population.
Yamakawa K; Tajima G; Keegan JW; Nakahori Y; Guo F; Seshadri AJ; Cahill LA; Lederer JA
J Leukoc Biol; 2021 Mar; 109(3):645-656. PubMed ID: 32531832
[TBL] [Abstract][Full Text] [Related]
25. Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response.
Sidders B; Zhang P; Goodwin K; O'Connor G; Russell DL; Borodovsky A; Armenia J; McEwen R; Linghu B; Bendell JC; Bauer TM; Patel MR; Falchook GS; Merchant M; Pouliot G; Barrett JC; Dry JR; Woessner R; Sachsenmeier K
Clin Cancer Res; 2020 May; 26(9):2176-2187. PubMed ID: 31953314
[TBL] [Abstract][Full Text] [Related]
26. A review of cancer immunotherapy toxicity.
Kennedy LB; Salama AKS
CA Cancer J Clin; 2020 Mar; 70(2):86-104. PubMed ID: 31944278
[TBL] [Abstract][Full Text] [Related]
27. Adenosine Metabolism: Emerging Concepts for Cancer Therapy.
Boison D; Yegutkin GG
Cancer Cell; 2019 Dec; 36(6):582-596. PubMed ID: 31821783
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
[TBL] [Abstract][Full Text] [Related]
29. Tumor-derived exosomes (TDEs): How to avoid the sting in the tail.
Wan M; Ning B; Spiegel S; Lyon CJ; Hu TY
Med Res Rev; 2020 Jan; 40(1):385-412. PubMed ID: 31318078
[TBL] [Abstract][Full Text] [Related]
30. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
Lux A; Kahlert C; Grützmann R; Pilarsky C
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
[TBL] [Abstract][Full Text] [Related]
31. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.
Czystowska-Kuzmicz M; Sosnowska A; Nowis D; Ramji K; Szajnik M; Chlebowska-Tuz J; Wolinska E; Gaj P; Grazul M; Pilch Z; Zerrouqi A; Graczyk-Jarzynka A; Soroczynska K; Cierniak S; Koktysz R; Elishaev E; Gruca S; Stefanowicz A; Blaszczyk R; Borek B; Gzik A; Whiteside T; Golab J
Nat Commun; 2019 Jul; 10(1):3000. PubMed ID: 31278254
[TBL] [Abstract][Full Text] [Related]
32. Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8
Zhang F; Li R; Yang Y; Shi C; Shen Y; Lu C; Chen Y; Zhou W; Lin A; Yu L; Zhang W; Xue Z; Wang J; Cai Z
Immunity; 2019 Mar; 50(3):738-750.e7. PubMed ID: 30770248
[TBL] [Abstract][Full Text] [Related]
33. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.
De Marchi E; Orioli E; Pegoraro A; Sangaletti S; Portararo P; Curti A; Colombo MP; Di Virgilio F; Adinolfi E
Oncogene; 2019 May; 38(19):3636-3650. PubMed ID: 30655604
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-targeted drug delivery.
Sharma A; Arambula JF; Koo S; Kumar R; Singh H; Sessler JL; Kim JS
Chem Soc Rev; 2019 Feb; 48(3):771-813. PubMed ID: 30575832
[TBL] [Abstract][Full Text] [Related]
35. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1
Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G
J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680
[TBL] [Abstract][Full Text] [Related]
36. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
37. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology.
Palmirotta R; Lovero D; Cafforio P; Felici C; Mannavola F; Pellè E; Quaresmini D; Tucci M; Silvestris F
Ther Adv Med Oncol; 2018; 10():1758835918794630. PubMed ID: 30181785
[TBL] [Abstract][Full Text] [Related]
38. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
Chen G; Huang AC; Zhang W; Zhang G; Wu M; Xu W; Yu Z; Yang J; Wang B; Sun H; Xia H; Man Q; Zhong W; Antelo LF; Wu B; Xiong X; Liu X; Guan L; Li T; Liu S; Yang R; Lu Y; Dong L; McGettigan S; Somasundaram R; Radhakrishnan R; Mills G; Lu Y; Kim J; Chen YH; Dong H; Zhao Y; Karakousis GC; Mitchell TC; Schuchter LM; Herlyn M; Wherry EJ; Xu X; Guo W
Nature; 2018 Aug; 560(7718):382-386. PubMed ID: 30089911
[TBL] [Abstract][Full Text] [Related]
39. Targeting adenosine for cancer immunotherapy.
Leone RD; Emens LA
J Immunother Cancer; 2018 Jun; 6(1):57. PubMed ID: 29914571
[TBL] [Abstract][Full Text] [Related]
40. NFATc1 Promotes Antitumoral Effector Functions and Memory CD8
Heim L; Friedrich J; Engelhardt M; Trufa DI; Geppert CI; Rieker RJ; Sirbu H; Finotto S
Cancer Res; 2018 Jul; 78(13):3619-3633. PubMed ID: 29691251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
